{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:34:16Z","timestamp":1793813656186,"version":"4.6.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Adverse events of chemotherapy may be caused by pharmacodynamics or psychological factors such as negative expectations, which constitute nocebo effects. In a randomized controlled trial, we examined whether educating patients about the nocebo effect is efficacious in reducing the intensity of self-reported adverse events.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this proof-of-concept study, <jats:italic>N<\/jats:italic>\u2009=\u2009100 outpatients (mean age: 60.2\u2009years, 65% male, 54% UICC tumour stage IV) starting first-line, de novo chemotherapy for gastrointestinal cancers were randomized 1:1 to a nocebo education (<jats:italic>n<\/jats:italic>\u2009=\u200949) or an attention control group (<jats:italic>n<\/jats:italic>\u2009=\u200951). Our primary outcome was patient-rated intensity of four chemotherapy-specific and three non-specific adverse events (rated on 11-point Likert scales) at 10-days and 12-weeks after the first course of chemotherapy. Secondary outcomes included perceived control of adverse events and tendency to misattribute symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>General linear models indicated that intensity of adverse events differed at 12-weeks after the first course of chemotherapy (mean difference: 4.04, 95% CI [0.72, 7.36], <jats:italic>p<\/jats:italic>\u2009=\u2009.02, <jats:italic>d<\/jats:italic>\u2009=\u20090.48), with lower levels in the nocebo education group. This was attributable to less non-specific adverse events (mean difference: 0.39, 95% CI [0.04, 0.73], <jats:italic>p<\/jats:italic>\u2009=\u2009.03, <jats:italic>d<\/jats:italic>\u2009=\u20090.44) and a trend towards less specific adverse events in the nocebo education group (mean difference: 0.36, 95% CI [\u2212\u20090.02, 0.74], <jats:italic>p<\/jats:italic>\u2009=\u2009.07, <jats:italic>d<\/jats:italic>\u2009=\u20090.37). We found no difference in adverse events at 10-days follow-up, perceived control of adverse events, or tendency to misattribute non-specific symptoms to the chemotherapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study provides first proof-of-concept evidence for the efficacy of a brief information session in preventing adverse events of chemotherapy. However, results regarding patient-reported outcomes cannot rule out response biases. Informing patients about the nocebo effect may be an innovative and clinically feasible intervention for reducing the burden of adverse events.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Retrospectively registered on March 27, 2018 to the German Clinical Trial Register (ID: DRKS00009501).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-022-10089-2","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T23:03:41Z","timestamp":1663887821000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Preventing adverse events of chemotherapy for gastrointestinal cancer by educating patients about the nocebo effect: a randomized-controlled trial"],"prefix":"10.1186","volume":"22","author":[{"given":"T.","family":"Michnevich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Oechsle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Nestoriuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"issue":"10","key":"10089_CR1","doi-asserted-by":"publisher","first-page":"e0184360","DOI":"10.1371\/journal.pone.0184360","volume":"12","author":"A Pearce","year":"2017","unstructured":"Pearce A, Haas M, Viney R, Pearson SA, Haywood P, Brown C, et al. Incidence and severity of self-reported chemotherapy side effects in routine care: a prospective cohort study. Ganti AK, editor. PLoS One. 2017;12(10):e0184360. https:\/\/doi.org\/10.1371\/journal.pone.0184360 [cited 2019 Apr 12]. Available from.","journal-title":"PLoS One"},{"issue":"9","key":"10089_CR2","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s40273-013-0081-2","volume":"31","author":"A Carlotto","year":"2013","unstructured":"Carlotto A, Hogsett VL, Maiorini EM, Razulis JG, Sonis ST. The economic burden of toxicities associated with Cancer treatment: review of the literature and analysis of nausea and vomiting, Diarrhoea, Oral Mucositis and Fatigue. Pharmacoeconomics. 2013;31(9):753\u201366.","journal-title":"Pharmacoeconomics"},{"issue":"12","key":"10089_CR3","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1007\/s00520-016-3346-4","volume":"24","author":"R Wagland","year":"2016","unstructured":"Wagland R, Richardson A, Ewings S, Armes J, Lennan E, Hankins M, et al. Prevalence of cancer chemotherapy-related problems, their relation to health-related quality of life and associated supportive care: a cross-sectional survey. Support Care Cancer. 2016;24(12):4901\u201311.","journal-title":"Support Care Cancer"},{"issue":"2","key":"10089_CR4","doi-asserted-by":"publisher","first-page":"e12618","DOI":"10.1111\/ecc.12618","volume":"26","author":"D Lorusso","year":"2017","unstructured":"Lorusso D, Bria E, Costantini A, Di Maio M, Rosti G, Mancuso A. Patients\u2019 perception of chemotherapy side effects: expectations, doctor-patient communication and impact on quality of life - an Italian survey. Eur J Cancer Care. 2017;26(2):e12618.","journal-title":"Eur J Cancer Care"},{"issue":"3","key":"10089_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.6004\/jnccn.2018.7098","volume":"17","author":"JM Jacobs","year":"2019","unstructured":"Jacobs JM, Ream ME, Pensak N, Nisotel LE, Fishbein JN. Patient experiences with Oral chemotherapy: adherence, symptoms, and quality of life. J Natl Compr Cancer Netw. 2019;17(3):221\u20138.","journal-title":"J Natl Compr Cancer Netw"},{"key":"10089_CR6","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1186\/s12885-015-1862-0","volume":"15","author":"G Clarke","year":"2015","unstructured":"Clarke G, Johnston S, Corrie P, Kuhn I, Barclay S. Withdrawal of anticancer therapy in advanced disease: a systematic literature review. BMC Cancer. 2015;15:892.","journal-title":"BMC Cancer"},{"issue":"7","key":"10089_CR7","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/pds.4169","volume":"26","author":"A Mahr","year":"2017","unstructured":"Mahr A, Golmard C, Pham E, Iordache L, Deville L, Faure P. Types, frequencies, and burden of nonspecific adverse events of drugs: analysis of randomized placebo-controlled clinical trials. Pharmacoepidemiol Drug Saf. 2017;26(7):731\u201341.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10089_CR8","first-page":"133","volume":"10","author":"A Barsky","year":"2002","unstructured":"Barsky A, Saintfort R, Rogers M, Borus J. Nonspecific medication side effects and the nocebo phenomenon. JAMA. 2002;10(1):133\u20134.","journal-title":"JAMA"},{"issue":"1","key":"10089_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/jnci\/95.1.19","volume":"95","author":"G Chvetzoff","year":"2003","unstructured":"Chvetzoff G, Tannock IF. Placebo effects in oncology. J Natl Cancer Inst. 2003;95(1):19\u201329.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10089_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12160-010-9186-4","volume":"40","author":"B Colagiuri","year":"2010","unstructured":"Colagiuri B, Zachariae R. Patient expectancy and post-chemotherapy nausea: a meta-analysis. Ann Behav Med. 2010;40(1):3\u201314.","journal-title":"Ann Behav Med"},{"issue":"6","key":"10089_CR11","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1001\/jama.2012.115%5Cn","volume":"307","author":"L Colloca","year":"2012","unstructured":"Colloca L, Finniss D. Nocebo effects, patient-clinician communication, and therapeutic outcomes. JAMA. 2012;307(6):567\u20138. https:\/\/doi.org\/10.1001\/jama.2012.115%5Cn Available from: http:\/\/www.embase.com\/search\/results?subaction=viewrecord&from=export&id=L364220204%5Cn. http:\/\/jama.ama-assn.org\/content\/307\/6\/567.full.pdf+html%5Cn. http:\/\/sfx.library.uu.nl\/utrecht?sid=EMBASE&issn=00987484&id=doi:.","journal-title":"JAMA"},{"issue":"46","key":"10089_CR12","doi-asserted-by":"publisher","first-page":"12014","DOI":"10.1523\/JNEUROSCI.2947-06.2006","volume":"26","author":"F Benedetti","year":"2006","unstructured":"Benedetti F, Amanzio M, Vighetti S, Asteggiano G. The biochemical and neuroendocrine bases of the Hyperalgesic nocebo effect. J Neurosci. 2006;26(46):12014\u201322.","journal-title":"J Neurosci"},{"issue":"2","key":"10089_CR13","doi-asserted-by":"publisher","first-page":"e585","DOI":"10.1097\/PR9.0000000000000585","volume":"2","author":"M Blasini","year":"2017","unstructured":"Blasini M, Corsi N, Klinger R, Colloca L. Nocebo and pain: an overview of the psychoneurobiological mechanisms. Pain Rep. 2017;2(2):e585.","journal-title":"Pain Rep"},{"issue":"3","key":"10089_CR14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/clpt.1987.142","volume":"42","author":"MG Myers","year":"1987","unstructured":"Myers MG, Cairns JA, Singer J. The consent form as a possible cause of side effects. Clin Pharmacol Ther. 1987;42(3):250\u20133.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10089_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000147951","volume":"112","author":"G Cocco","year":"2009","unstructured":"Cocco G. Erectile dysfunction after therapy with metoprolol: the Hawthorne effect. Cardiology. 2009;112(3):174\u20137.","journal-title":"Cardiology"},{"issue":"6","key":"10089_CR16","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1111\/j.1743-6109.2007.00563.x","volume":"4","author":"N Mondaini","year":"2007","unstructured":"Mondaini N, Gontero P, Giubilei G, Lombardi G, Cai T, Gavazzi A, et al. Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon? J Sex Med. 2007;4(6):1708\u201312.","journal-title":"J Sex Med"},{"key":"10089_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/pds.2067","volume":"20","author":"W Rief","year":"2011","unstructured":"Rief W, Barsky AJ, Glombiewski JA, Nestoriuc Y, Gaesmer H, Braehler E. Assessing general side effects in clinical trials: reference data from the general population. Pharmacoepidemiol Drug Saf. 2011;20:405\u201315 Available from: http:\/\/eprints.dinus.ac.id\/15172\/1\/jurnal_14778.pdf.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10089_CR18","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1146\/annurev-psych-010418-102907","volume":"70","author":"KJ Petrie","year":"2018","unstructured":"Petrie KJ, Rief W. Psychobiological mechanisms of placebo and nocebo effects: pathways to improve treatments and reduce side effects. Annu Rev Psychol. 2018;70(1):599\u2013625.","journal-title":"Annu Rev Psychol"},{"issue":"6","key":"10089_CR19","doi-asserted-by":"publisher","first-page":"e005374","DOI":"10.1136\/bmjopen-2014-005374","volume":"4","author":"KJ Petrie","year":"2014","unstructured":"Petrie KJ, Faasse K, Crichton F, Grey A. How common are symptoms? Evidence from a New Zealand national telephone survey. BMJ Open. 2014;4(6):e005374 [cited 2019 Apr 9]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24928596.","journal-title":"BMJ Open"},{"issue":"2","key":"10089_CR20","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/bjhp.12298","volume":"23","author":"RK Webster","year":"2018","unstructured":"Webster RK, Weinman J, Rubin GJ. Medicine-related beliefs predict attribution of symptoms to a sham medicine: a prospective study. Br J Health Psychol. 2018;23(2):436\u201354.","journal-title":"Br J Health Psychol"},{"issue":"June","key":"10089_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ctrv.2018.06.009","volume":"68","author":"C Fletcher","year":"2018","unstructured":"Fletcher C, Wilson C, Hutchinson AD, Grunfeld EA. The relationship between anticipated response and subsequent experience of cancer treatment-related side effects: a meta-analysis comparing effects before and after treatment exposure. Cancer Treat Rev. 2018;68(June):86\u201393. https:\/\/doi.org\/10.1016\/j.ctrv.2018.06.009.","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"10089_CR22","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jpainsymman.2009.01.008","volume":"38","author":"SJ Sohl","year":"2009","unstructured":"Sohl SJ, Schnur JB, Montgomery GH. A Meta-analysis of the relationship between response expectancies and Cancer treatment-related side effects. J Pain Symptom Manag. 2009;38(5):775\u201384.","journal-title":"J Pain Symptom Manag"},{"issue":"10","key":"10089_CR23","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1093\/annonc\/mdw266","volume":"27","author":"Y Nestoriuc","year":"2016","unstructured":"Nestoriuc Y, von Blanckenburg P, Schuricht F, Barsky AJ, Hadji P, Albert US, et al. Is it best to expect the worst? Influence of patients\u2019 side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort study. Ann Oncol. 2016;27(10):1909\u201315.","journal-title":"Ann Oncol"},{"issue":"1","key":"10089_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.32872\/cpe.v2i1.2695","volume":"2","author":"MC Shedden-Mora","year":"2020","unstructured":"Shedden-Mora MC, Pan Y, Heisig SR, von Blanckenburg P, Rief W, Witzel I, et al. Optimizing expectations about endocrine treatment for breast cancer: results of the randomized controlled psy-breast trial. Clin Psychol Europe. 2020;2(1):1\u201320.","journal-title":"Clin Psychol Europe"},{"issue":"July","key":"10089_CR25","first-page":"1","volume":"10","author":"Y Pan","year":"2019","unstructured":"Pan Y, Kinitz T, Stapic M, Nestoriuc Y. Minimizing drug adverse events by informing about the nocebo effect\u2014an experimental study. Front Psychiatry. 2019;10(July):1\u201312.","journal-title":"Front Psychiatry"},{"key":"10089_CR26","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.envres.2015.04.016","volume":"140","author":"F Crichton","year":"2015","unstructured":"Crichton F, Petrie KJ. Health complaints and wind turbines: the efficacy of explaining the nocebo response to reduce symptom reporting. Environ Res. 2015;140:449\u201355.","journal-title":"Environ Res"},{"issue":"7","key":"10089_CR27","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/pon.5108","volume":"28","author":"J Miceli","year":"2019","unstructured":"Miceli J, Geller D, Tsung A, Hecht CL, Wang Y, Pathak R, et al. Illness perceptions and perceived stress in patients with advanced gastrointestinal cancer. Psycho-Oncology. 2019;28(7):1513\u20139.","journal-title":"Psycho-Oncology"},{"issue":"2","key":"10089_CR28","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1245\/s10434-012-2663-1","volume":"20","author":"YRBM van Gestel","year":"2013","unstructured":"van Gestel YRBM, Lemmens VEPP, de Hingh IHJT, Steevens J, Rutten HJT, Nieuwenhuijzen GAP, et al. Influence of comorbidity and age on 1-, 2-, and 3-month postoperative mortality rates in gastrointestinal Cancer patients. Ann Surg Oncol. 2013;20(2):371\u201380.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10089_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/1097-0142(19950715)76:2<167::AID-CNCR2820760203>3.0.CO;2-K","volume":"76","author":"SM Miller","year":"1980","unstructured":"Miller SM. Monitoring versus blunting styles of coping with cancer influence the information patients want and need about their disease. Cancer. 1980;76(2):167\u201377.","journal-title":"Cancer"},{"key":"10089_CR30","volume-title":"Seite an Seite - eine gyn\u00e4kologische Krebserkrankung in der Partnerschaft gemeinsam bew\u00e4ltigen: ein Ratgeber f\u00fcr Paare","author":"Z Tanja","year":"2008","unstructured":"Tanja Z, Nina H. Seite an Seite - eine gyn\u00e4kologische Krebserkrankung in der Partnerschaft gemeinsam bew\u00e4ltigen: ein Ratgeber f\u00fcr Paare. G\u00f6ttingen: Hogrefe; 2008. [cited 2019 Apr 2]. Available from: https:\/\/www.hogrefe.de\/shop\/seite-an-seite-eine-gynaekologische-krebserkrankung-in-der-partnerschaft-gemeinsam-bewaeltigen-65856.html"},{"issue":"3","key":"10089_CR31","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","volume":"11","author":"DF Cella","year":"1993","unstructured":"Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of Cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570\u20139.","journal-title":"J Clin Oncol"},{"issue":"1","key":"10089_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-018-4814-7","volume":"18","author":"J Quidde","year":"2018","unstructured":"Quidde J, Pan Y, Salm M, Hendi A, Nilsson S, Oechsle K, et al. Preventing adverse events of chemotherapy by educating patients about the nocebo effect (RENNO study) \u2013 study protocol of a randomized controlled trial with gastrointestinal cancer patients. BMC Cancer. 2018;18(1):1\u20138.","journal-title":"BMC Cancer"},{"issue":"1","key":"10089_CR33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1742-5573-1-6","volume":"1","author":"JH Abramson","year":"2004","unstructured":"Abramson JH. WINPEPI (PEPI-for-windows): computer programs for epidemiologists. Epidemiol Perspect Innov. 2004;1(1):6.","journal-title":"Epidemiol Perspect Innov"},{"issue":"1","key":"10089_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10865-009-9227-2","volume":"33","author":"S Schneider","year":"2010","unstructured":"Schneider S, Moyer A, Knapp-Oliver S, Sohl S, Cannella D, Targhetta V. Pre-intervention distress moderates the efficacy of psychosocial treatment for cancer patients: a meta-analysis. J Behav Med. 2010;33(1):1\u201314.","journal-title":"J Behav Med"},{"issue":"16","key":"10089_CR35","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","volume":"18","author":"A de Gramont","year":"2000","unstructured":"de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 2000;18(16):2938\u201347.","journal-title":"J Clin Oncol"},{"issue":"27","key":"10089_CR36","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1200\/JCO.2006.09.8467","volume":"25","author":"E D\u00edaz-Rubio","year":"2007","unstructured":"D\u00edaz-Rubio E, Tabernero J, G\u00f3mez-Espa\u00f1a A, Massut\u00ed B, Sastre J, Chaves M, et al. Phase III study of capecitabine plus oxaliplatin compared with continuous-infusion fluorouracil plus oxaliplatin as first-line therapy in metastatic colorectal cancer: final report of the Spanish cooperative group for the treatment of digestive tumors trial. J Clin Oncol. 2007;25(27):4224\u201330.","journal-title":"J Clin Oncol"},{"issue":"1","key":"10089_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1056\/NEJMoa073149","volume":"358","author":"D Cunningham","year":"2008","unstructured":"Cunningham D, Starling N, Rao S, Iveson T, Nicolson M, Coxon F, et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med. 2008;358(1):36\u201346.","journal-title":"N Engl J Med"},{"issue":"19","key":"10089_CR38","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"T Conroy","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M, Bouch\u00e9 O, Guimbaud R, B\u00e9couarn Y, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364(19):1817\u201325.","journal-title":"N Engl J Med"},{"issue":"14","key":"10089_CR39","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273\u201381.","journal-title":"N Engl J Med"},{"key":"10089_CR40","first-page":"03","volume":"4","author":"National Cancer Institute","year":"2010","unstructured":"National Cancer Institute. Common terminology criteria for adverse events (CTCAE). Version. 2010;4:03.","journal-title":"Version"},{"key":"10089_CR41","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/1471-2407-13-426","volume":"13","author":"P von Blanckenburg","year":"2013","unstructured":"von Blanckenburg P, Schuricht F, Albert US, Rief W, Nestoriuc Y. Optimizing expectations to prevent side effects and enhance quality of life in breast cancer patients undergoing endocrine therapy: study protocol of a randomized controlled trial. BMC Cancer. 2013;13:426.","journal-title":"BMC Cancer"},{"key":"10089_CR42","unstructured":"TNM | UICC [Internet]. [cited 2020 Jan 22]. Available from: https:\/\/www.uicc.org\/resources\/tnm"},{"issue":"January","key":"10089_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/CLEP.S72247","volume":"7","author":"K Biering","year":"2015","unstructured":"Biering K, Hjollund NH, Frydenberg M. Using multiple imputation to deal with missing data and attrition in longitudinal studies with repeated measures of patient-reported outcomes. Clin Epidemiol. 2015;7(January):91\u2013106.","journal-title":"Clin Epidemiol"},{"key":"10089_CR44","volume-title":"Multiple imputation for nonresponse in surveys","author":"DB Rubin","year":"2004","unstructured":"Rubin DB. Multiple imputation for nonresponse in surveys, vol. 81. New York: Wiley; 2004."},{"key":"10089_CR45","doi-asserted-by":"crossref","unstructured":"Van Buuren S. Flexible imputation of missing data: CRC press; 2018.","DOI":"10.1201\/9780429492259"},{"key":"10089_CR46","volume-title":"IBM SPSS statistics for windows","author":"IBM Corp","year":"2017","unstructured":"IBM Corp. IBM SPSS statistics for windows. New York: Armonk; 2017."},{"key":"10089_CR47","volume-title":"Multilevel modeling: applications in STATA, IBM SPSS, SAS, R, & HLM","author":"GD Garson","year":"2019","unstructured":"Garson GD. Multilevel modeling: applications in STATA, IBM SPSS, SAS, R, & HLM. Newbury Park, CA: SAGE Publications, Inc; 2019."},{"key":"10089_CR48","volume-title":"Experimental design: procedures for the behavioral sciences. Experimental Design: Procedures for the Behavioral Sciences","author":"R Kirk","year":"2014","unstructured":"Kirk R. Experimental design: procedures for the behavioral sciences. Experimental Design: Procedures for the Behavioral Sciences. Newbury Park, CA: SAGE Publications, Inc.; 2014."},{"key":"10089_CR49","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1037\/0022-3514.51.6.1173","volume":"51","author":"R Baron","year":"1986","unstructured":"Baron R, Kenny D. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173\u201382.","journal-title":"J Pers Soc Psychol"},{"key":"10089_CR50","volume-title":"Monte Carlo method for assessing mediation: an interactive tool for creating confidence intervals for indirect effects","author":"JP Selig","year":"2008","unstructured":"Selig JP, Preacher KJ. Monte Carlo method for assessing mediation: an interactive tool for creating confidence intervals for indirect effects; 2008."},{"issue":"1","key":"10089_CR51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1037\/1082-989X.7.1.83","volume":"7","author":"DP MacKinnon","year":"2002","unstructured":"MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods. 2002;7(1):83.","journal-title":"Psychol Methods"},{"issue":"17","key":"10089_CR52","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1200\/JCO.2004.03.025","volume":"22","author":"EK Fromme","year":"2004","unstructured":"Fromme EK, Eilers KM, Mori M, Hsieh YC, Beer TM. How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. J Clin Oncol. 2004;22(17):3485\u201390 [cited 2020 Feb 17]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15337796.","journal-title":"J Clin Oncol"},{"issue":"9","key":"10089_CR53","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s00520-010-0969-8","volume":"19","author":"ER Greimel","year":"2011","unstructured":"Greimel ER, Bjelic-Radisic V, Pfisterer J, Hilpert F, Daghofer F, Pujade-Lauraine E, et al. Toxicity and quality of life outcomes in ovarian cancer patients participating in randomized controlled trials. Support Care Cancer. 2011;19(9):1421\u20137 [cited 2020 Feb 17]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20694564.","journal-title":"Support Care Cancer"},{"issue":"12","key":"10089_CR54","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1037\/hea0000416","volume":"35","author":"RK Webster","year":"2016","unstructured":"Webster RK, Weinman J, James RG. A systematic review of factors that contribute to nocebo effects. Health Psychol. 2016;35(12):1334\u201355.","journal-title":"Health Psychol"},{"key":"10089_CR55","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ejphar.2013.09.071","volume":"722","author":"MA Tejani","year":"2013","unstructured":"Tejani MA, Chandwani K, Janelsins M, Peoples AR, Kamen C, Morrow GR, et al. Anticipatory nausea and vomiting due to chemotherapy. Eur J Pharmacol. 2013;722:172\u20139. https:\/\/doi.org\/10.1016\/j.ejphar.2013.09.071.","journal-title":"Eur J Pharmacol"},{"key":"10089_CR56","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/bs.irn.2018.07.011","volume":"139","author":"JM Kelley","year":"2018","unstructured":"Kelley JM. Lumping and Splitting: Toward a taxonomy of placebo and related effects. Int Rev Neurobiol. 2018;139:29\u201348 [cited 2019 Mar 25]. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0074774218300400?via%3Dihub.","journal-title":"Int Rev Neurobiol"},{"key":"10089_CR57","doi-asserted-by":"publisher","unstructured":"Sommariva S, Pongiglione B, Tarricone R. Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: A systematic review. Crit Rev Oncol Hematol. 2016;99:13\u201336. https:\/\/doi.org\/10.1016\/j.critrevonc.2015.12.001.","DOI":"10.1016\/j.critrevonc.2015.12.001"},{"key":"10089_CR58","doi-asserted-by":"publisher","unstructured":"Bower JE. Cancer-related fatigue--mechanisms, risk factors, and treatments. Nat Rev Clin Oncol. 2014;11(10):597\u2013609. https:\/\/doi.org\/10.1038\/nrclinonc.2014.127.","DOI":"10.1038\/nrclinonc.2014.127"},{"issue":"March","key":"10089_CR59","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fphar.2019.00167","volume":"10","author":"K Barnes","year":"2019","unstructured":"Barnes K, Faasse K, Geers AL, Helfer SG, Sharpe L, Colloca L, et al. Can positive framing reduce nocebo side effects? Current evidence and recommendation for future research. Front Pharmacol. 2019;10(March):167.","journal-title":"Front Pharmacol"},{"issue":"11","key":"10089_CR60","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/S0895-4356(96)00177-1","volume":"49","author":"AM O\u2019Connor","year":"1996","unstructured":"O\u2019Connor AM, Pennie RA, Dales RE. Framing effects on expectations, decisions, and side effects experienced: the case of influenza immunization. J Clin Epidemiol. 1996;49(11):1271\u20136.","journal-title":"J Clin Epidemiol"},{"key":"10089_CR61","doi-asserted-by":"publisher","unstructured":"Mosher CE, Winger JG, Given BA, Shahda S, Helft PR. A systematic review of psychosocial interventions for colorectal cancer patients. Support Care Cancer. 2017;25(7):2349\u201362. https:\/\/doi.org\/10.1007\/s00520-017-3693-9.","DOI":"10.1007\/s00520-017-3693-9"},{"issue":"11","key":"10089_CR62","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/pon.899","volume":"14","author":"L Ross","year":"2005","unstructured":"Ross L, Thomsen BL, Karlsen RV, Boesen EH, Johansen C. A randomized psychosocial intervention study on the effect of home visits on the well-being of Danish colorectal cancer patients - the INCA project. Psycho-Oncology. 2005;14(11):949\u201361.","journal-title":"Psycho-Oncology"},{"issue":"3","key":"10089_CR63","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/pon.638","volume":"12","author":"YL Cheung","year":"2003","unstructured":"Cheung YL, Molassiotis A, Chang AM. The effect of progressive muscle relaxation training on anxiety and quality of life after stoma surgery in colorectal cancer patients. Psycho-Oncology. 2003;12(3):254\u201366.","journal-title":"Psycho-Oncology"},{"issue":"8","key":"10089_CR64","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/cncr.29906","volume":"122","author":"JL Steel","year":"2016","unstructured":"Steel JL, Geller DA, Kim KH, Butterfield LH, Spring M, Grady J, et al. Web-based collaborative care intervention to manage cancer-related symptoms in the palliative care setting. Cancer. 2016;122(8):1270\u201382.","journal-title":"Cancer"},{"issue":"3","key":"10089_CR65","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1300\/J077v25n03_02","volume":"25","author":"JL Steel","year":"2007","unstructured":"Steel JL, Nadeau K, Olek M, Carr BI. Preliminary results of an individually tailored psychosocial intervention for patients with advanced hepatobiliary carcinoma. J Psychosoc Oncol. 2007;25(3):19\u201342.","journal-title":"J Psychosoc Oncol"},{"issue":"5","key":"10089_CR66","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00520-013-2069-z","volume":"22","author":"G Pettersson","year":"2014","unstructured":"Pettersson G, Berter\u00f6 C, Unosson M, B\u00f6rjeson S. Symptom prevalence, frequency, severity, and distress during chemotherapy for patients with colorectal cancer. Support Care Cancer. 2014;22(5):1171\u20139.","journal-title":"Support Care Cancer"},{"key":"10089_CR67","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0885-3924(92)90062-M","volume":"7","author":"TG Burish","year":"1992","unstructured":"Burish TG, Tope DM. Psychological techniques for controlling the adverse side effects of cancer chemotherapy: findings from a decade of research. J Pain Symptom Manag. 1992;7:287\u2013301.","journal-title":"J Pain Symptom Manag"},{"issue":"3","key":"10089_CR68","first-page":"CD007730","volume":"2013","author":"DA Scott","year":"2013","unstructured":"Scott DA, Mills M, Black A, Cantwell M, Campbell A, Cardwell CR, et al. Multidimensional rehabilitation programmes for adult cancer survivors. Cochrane Database Syst Rev. 2013;2013(3):CD007730.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10089_CR69","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2190\/U0P3-5VPV-YXKF-GRG1","volume":"31","author":"L Edgar","year":"2001","unstructured":"Edgar L, Rosberger Z, Collet JP. Lessons learned: outcomes and methodology of a coping skills intervention trial comparing individual and group formats for patients with cancer. Int J Psychiatry Med. 2001;31(3):289\u2013304.","journal-title":"Int J Psychiatry Med"},{"issue":"February","key":"10089_CR70","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejon.2018.03.002","volume":"34","author":"A Coolbrandt","year":"2018","unstructured":"Coolbrandt A, Milisen K, Wildiers H, Aertgeerts B, van Achterberg T, Van der Elst E, et al. A nursing intervention aimed at reducing symptom burden during chemotherapy (CHEMO-SUPPORT): a mixed-methods study of the patient experience. Eur J Oncol Nurs. 2018;34(February):35\u201341.","journal-title":"Eur J Oncol Nurs"},{"issue":"4","key":"10089_CR71","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1037\/0022-006X.59.4.518","volume":"59","author":"TG Burish","year":"1991","unstructured":"Burish TG, Snyder SL, Jenkins RA. Preparing patients for cancer chemotherapy: effect of coping preparation and relaxation interventions. J Consult Clin Psychol. 1991;59(4):518\u201325.","journal-title":"J Consult Clin Psychol"},{"issue":"24","key":"10089_CR72","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1001\/jama.2017.16216","volume":"318","author":"AJ Barsky","year":"2017","unstructured":"Barsky AJ. The iatrogenic potential of the physician\u2019s words. JAMA. 2017;318(24):2425\u20136.","journal-title":"JAMA"},{"issue":"9","key":"10089_CR73","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/jnci\/djj159","volume":"98","author":"SA Dobie","year":"2006","unstructured":"Dobie SA, Baldwin LM, Dominitz JA, Matthews B, Billingsley K, Barlow W. Completion of therapy by Medicare patients with stage III Colon Cancer. JNCI. 2006;98(9):610\u20139.","journal-title":"JNCI"},{"key":"10089_CR74","first-page":"h2147","volume":"350","author":"K Loudon","year":"2015","unstructured":"Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ (Online). 2015;350:h2147.","journal-title":"BMJ (Online)"},{"key":"10089_CR75","unstructured":"Clinical presentation, diagnosis, and staging of colorectal cancer - UpToDate [Internet]. [cited 2020 Feb 12]. Available from: https:\/\/www.uptodate.com\/contents\/clinical-presentation-diagnosis-and-staging-of-colorectal-cancer?search=colorectalcancer&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1."},{"key":"10089_CR76","unstructured":"Clinical features, diagnosis, and staging of gastric cancer - UpToDate [Internet]. [cited 2020 Feb 12]. Available from: https:\/\/www.uptodate.com\/contents\/clinical-features-diagnosis-and-staging-of-gastric-cancer?search=gastriccancer&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H45647872."},{"issue":"1","key":"10089_CR77","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF02353715","volume":"24","author":"S Fine","year":"1993","unstructured":"Fine S, Johnston C. Drug and placebo side effects in methylphenidate-placebo trial for attention deficit hyperactivity disorder. Child Psychiatry Hum Dev. 1993;24(1):25\u201330.","journal-title":"Child Psychiatry Hum Dev"},{"issue":"3","key":"10089_CR78","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/pon.1223","volume":"17","author":"KL Rodriguez","year":"2008","unstructured":"Rodriguez KL, Gambino FJ, Butow PN, Hagerty RG, Arnold RM. \u2018It\u2019s going to shorten your life\u2019: framing of oncologist\u2013patient communication about prognosis. Psycho-Oncology. 2008;17(3):219\u201325.","journal-title":"Psycho-Oncology"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-10089-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-022-10089-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-10089-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:06:08Z","timestamp":1663891568000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-022-10089-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["10089"],"URL":"https:\/\/doi.org\/10.1186\/s12885-022-10089-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"assertion":[{"value":"21 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial was approved by the University of Hamburg ethics committee (ID: 2015_03). All methods were carried out in accordance with the Declaration of Helsinki. All participants provided written informed consent prior enrolment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1008"}}